L-Glutamic γ-monohydroxamate [CAS 1955-67-5]

L-Glutamic γ-monohydroxamate is an antitumor agent, inhibits cell proliferation. L-Glutamic γ-monohydroxamate selectively inhibits the uptake of L-histidine into microvascular endothelial cell. L-Glutamic γ-monohydroxamate, as a vanadium ligand, activates glucose uptake and metabolism, thus decreases the blood glucose levels in vivo[1][2][3].

[1955-67-5]

C5H10N2O4

162.14

N[C@H](C(O)=O)CCC(NO)=O

Others

99.66

H2O : 83.33 mg/mL (ultrasonic)

-20°C, 3 years (Powder)

Blue Ice

H302, H315, H319, H335

H302, H315, H319, H335